Three once-weekly intra-articular injections of Hylan G-F 20 significantly improve pain relief compared with placebo in patients with chronic idiopathic knee osteoarthritis: a single-centre, evaluator-blinded and patient-blinded, randomized controlled trial

Michael Langworthy, Peter Lascarides, Wilson Ngai, Kevin Steele, Yili Huang

Article Type

Original Research

Published

This study was conducted to determine the efficacy and safety of three once-weekly injections of intra-articular Hylan G-F 20 in patients with chronic knee osteoarthritis over 26 weeks. It was hypothesized that Hylan G-F 20 would provide significant pain relief with no increased safety risk compared with IA saline (placebo).

Read more

Upadacitinib for the treatment of psoriatic arthritis

Diogo Fonseca, Miguel Nogueira, Tiago Torres

Article Type

Review

Published

This article offers a review of the more recently published results on the Janus kinase inhibitor inhibitor upadacitinib and its use in the treatment of psoriatic arthritis.

Read more

Real-world treatment patterns for repository corticotropin injection in patients with rheumatoid arthritis

Howard Busch, George J Wan, John Niewoehner, Parul Houston, Yujie Su, Cassie Clinton, Mary P Panaccio

Article Type

Original Research

Published

This study aims to describe real-world use and outcomes of patients with rheumatoid arthritis prescribed repository corticotropin injection in clinical practice through retrospective analysis of an electronic medical record database.

Read more

Register for alerts

I would like to be contacted by Drugs in Context when new articles are posted.